Cargando…

Covid-19 vaccine apps should deliver more to patients

Detalles Bibliográficos
Autores principales:	Dasgupta, Nabarun, Lazard, Allison, Brownstein, John S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057719/ https://www.ncbi.nlm.nih.gov/pubmed/33642239 http://dx.doi.org/10.1016/S2589-7500(21)00021-2

Ejemplares similares

Safety of COVID-19 vaccines: who should see an allergist
Publicado: (2021)

Epidemiology, not geopolitics, should guide COVID-19 vaccine donations
por: Bollyky, Thomas J, et al.
Publicado: (2021)

COVID-19 vaccination and cancer immunotherapy: should they stick together?
por: Brest, Patrick, et al.
Publicado: (2021)

COVID-19 vaccine trials should seek worthwhile efficacy
por: Krause, Philip, et al.
Publicado: (2020)

COVID-19 vaccine: what are we doing and what should we do?
por: Candelli, Marcello
Publicado: (2022)

Symptom study app provides real-world data on COVID-19 vaccines
por: Drury, Ruth E, et al.
Publicado: (2021)

COVID-19: when should quarantine be enforced?
por: Bauch, Chris T, et al.
Publicado: (2020)

Long-term effect of COVID-19 infection on hemodialysis patients: Should we follow hemodialysis patients more closely?
por: Demiray, Atalay, et al.
Publicado: (2021)

The COVID-19 vaccines rush: participatory community engagement matters more than ever
por: Burgess, Rochelle Ann, et al.
Publicado: (2021)

Should COVID-19 take advice from rheumatologists?
por: Kernan, Kate F, et al.
Publicado: (2020)

Delivering evidence-based critical care for mechanically ventilated patients with COVID-19
por: Salluh, Jorge I F, et al.
Publicado: (2020)

Public attitudes toward COVID-19 vaccination: The role of vaccine attributes, incentives, and misinformation
por: Kreps, Sarah, et al.
Publicado: (2021)

US COVID-19 clinical trial leadership gender disparities
por: Sehgal, Neil K R, et al.
Publicado: (2023)

The starting line for COVID-19 vaccine development
por: Lee, Nelson, et al.
Publicado: (2020)

Observational study of UK mobile health apps for COVID-19
por: Chidambaram, Swathikan, et al.
Publicado: (2020)

Haemoperfusion should only be used for COVID-19 in the context of randomized trials
por: Clark, Edward G., et al.
Publicado: (2020)

Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19
por: Wang, Tao, et al.
Publicado: (2020)

Clinicians should be more prone to examine children with chronic kidney disease in terms of vitamin D deficiency
por: Balta, Sevket, et al.
Publicado: (2013)

Should we ration extracorporeal membrane oxygenation during the COVID-19 pandemic?
por: Supady, Alexander, et al.
Publicado: (2021)

The immune-modulatory effects of exercise should be favorably harnessed against COVID-19
por: Codella, R., et al.
Publicado: (2020)

More light on cancer and COVID-19 reciprocal interaction
por: Brest, Patrick, et al.
Publicado: (2021)

COVID-19 vaccines in patients with cancer
por: Trapani, Dario, et al.
Publicado: (2021)

RAS inhibition and COVID-19: more questions than answers?
por: Kerneis, Mathieu, et al.
Publicado: (2021)

More evidence for worse COVID-19 outcomes in people with HIV
por: Boffito, Marta, et al.
Publicado: (2021)

Diabetes and covid-19: more than the sum of two morbidities
por: Pititto, Bianca de Almeida, et al.
Publicado: (2020)

COVID-19 vaccines for patients with haematological conditions
por: Sun, Clare, et al.
Publicado: (2021)

COVID-19 vaccination in patients receiving dialysis
por: Wilde, Benjamin, et al.
Publicado: (2021)

Should UK Pneumococcal Vaccine Eligibility Criteria Include Alcohol Dependency in Areas with High Alcohol-Related Mortality?
por: Mooney, John D., et al.
Publicado: (2018)

COVID-19 and ECMO: a call for close cooperation and more investigation
por: Lorusso, Roberto, et al.
Publicado: (2021)

Antithrombotic prophylaxis for symptomatic outpatients with COVID-19: less is consistently more
por: Connors, Jean M, et al.
Publicado: (2022)

ECMO for severe ARDS associated with COVID-19: now we know we can, but should we?
por: Shekar, Kiran, et al.
Publicado: (2020)

Perspective of patients with autoimmune diseases on COVID-19 vaccination
por: Boekel, Laura, et al.
Publicado: (2021)

When and which patients should receive remdesivir?
por: Garcia-Vidal, Carolina, et al.
Publicado: (2022)

Counting stillbirths and COVID 19—there has never been a more urgent time
por: Homer, Caroline S E, et al.
Publicado: (2021)

Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population
por: Hooijberg, Femke, et al.
Publicado: (2020)

COVID-19 vaccine hesitancy
por: Dubé, Eve, et al.
Publicado: (2022)

Incentives for COVID-19 vaccination
por: Brewer, Noel T., et al.
Publicado: (2022)

COVID-19 vaccinations for children
por: Mariatulqabtiah, Abdul Razak, et al.
Publicado: (2022)

How policymakers and other leaders can build a more sustainable post-COVID-19 ‘normal’
por: Bragge, Peter, et al.
Publicado: (2022)

An issue of trust—vaccinating Black patients against COVID-19
por: Okorodudu, Dale O, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7q53urm19gsfoqtf7q9t841pnb